Involvement of MAP3K8 and miR-17-5p in Poor Virologic Response to Interferon-Based Combination Therapy for Chronic Hepatitis C

• Akihito Tsubota ,

  * E-mail: atsubo@jikei.ac.jp

  Affiliations Institute of Clinical Medicine and Research (ICMR), Jikei University School of Medicine, Kashiwa, Chiba, Japan, Division of Gastroenterology and Hepatology, Kashiwa Hospital, The Jikei University School of Medicine, Kashiwa, Chiba, Japan

  ⨯
• Kaoru Mogushi,

  Affiliation Department of Bioinformatics, Medical Research Institute, Tokyo Medical and Dental University, Bunkyo-ku, Tokyo, Japan

  ⨯
• Hideki Aizaki,

  Affiliation Department of Virology II, National Institute of Infectious Diseases, Shinjuku-ku, Tokyo, Japan

  ⨯
• Ken Miyaguchi,

  Affiliation Department of Bioinformatics, Medical Research Institute, Tokyo Medical and Dental University, Bunkyo-ku, Tokyo, Japan

  ⨯
• Keisuke Nagatsuma,

  Affiliations Institute of Clinical Medicine and Research (ICMR), Jikei University School of Medicine, Kashiwa, Chiba, Japan, Division of Gastroenterology and Hepatology, Kashiwa Hospital, The Jikei University School of Medicine, Kashiwa, Chiba, Japan

  ⨯
• Hiroshi Matsudaira,

  Affiliations Institute of Clinical Medicine and Research (ICMR), Jikei University School of Medicine, Kashiwa, Chiba, Japan, Division of Gastroenterology and Hepatology, Kashiwa Hospital, The Jikei University School of Medicine, Kashiwa, Chiba, Japan

  ⨯
• Tatsuya Kushida,

  Affiliation National Bioscience Database Center, Japan Science and Technology Agency, Chiyoda-ku, Tokyo, Japan

  ⨯
• Tomomi Furihata,

  Affiliation Laboratory of Pharmacology and Toxicology, Graduate School of Pharmaceutical Science, Chiba University, Chiba, Japan

  ⨯
• Hiroshi Tanaka,

  Affiliation Department of Bioinformatics, Medical Research Institute, Tokyo Medical and Dental University, Bunkyo-ku, Tokyo, Japan

  ⨯
• Tomokazu Matsuura

  Affiliation Department of Laboratory Medicine, Jikei University School of Medicine, Minato-ku, Tokyo, Japan

  ⨯